*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Specialty pharmaceutical company Diurnal Group announced on Monday that its marketing and distribution partner, Medison Pharma has successfully submitted a market authorisation application (MAA) for its ‘Alkindi’ (hydrocortisone granules in capsules for opening) product to the Ministry of Health in Israel.
Independent Oil and Gas updated on the funding and progress of its two-phase Southern North Sea (SNS) core project on Monday, reporting that its focus remained on reaching a final investment decision (FID) at the earliest feasible time on the project.
Laura Ashley on Monday denied receiving a takeover offer after weekend reports that entrepreneur Michael Flacks will make a bid for the struggling retailer.
